Compugen Ltd
NASDAQ:CGEN
Compugen Ltd
NASDAQ:CGEN
Price:
1.91 USD
-3.54%
Updated:
Apr 25, 2024
Compugen Ltd
Net Income (Common)
|
Compugen Ltd
Net Income (Common) Peer Comparison
Comparables:
Q
QNRX
B
BOLT
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Compugen Ltd
NASDAQ:CGEN
|
Net Income (Common)
-$18.8m
|
CAGR 3-Years
14%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-6%
|
|
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
Net Income (Common)
-$8.7m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
Net Income (Common)
-₪26m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-3%
|
See Also
What is Compugen Ltd's Net Income (Common)?
Net Income (Common)
-18.8m
USD
-18.8m
USD
Based on the financial report for Dec 31, 2023, Compugen Ltd's Net Income (Common) amounts to -18.8m USD.
What is Compugen Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-6%
-6%
Over the last year, the Net Income (Common) growth was 44%. The average annual Net Income (Common) growth rates for Compugen Ltd have been 14% over the past three years , 4% over the past five years , and -6% over the past ten years .
You don't have any saved screeners yet
